Thursday, August 7, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Cleveland Clinic research findings may lead to improved treatments for chemotherapy-resistant ovarian cancer

June 10, 2024
in Cancer
Reading Time: 3 mins read
0
66
SHARES
602
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT
ADVERTISEMENT

Monday, June 10, 2024, CLEVELAND: Cleveland Clinic researchers have discovered a new location for a protein that helps ovarian cancer cells resist chemotherapy treatments and that fosters aggressive cancer stem cell growth.

Monday, June 10, 2024, CLEVELAND: Cleveland Clinic researchers have discovered a new location for a protein that helps ovarian cancer cells resist chemotherapy treatments and that fosters aggressive cancer stem cell growth.

 

These findings, published today in Molecular Cancer, may become the basis of a new approach to treat chemotherapy-resistant ovarian cancer that targets the protein CD55. Currently the CD55 protein is difficult to target because of its protective role in the immune system and its location on the cell surface.

 

Ofer Reizes, Ph.D., the Laura J. Fogarty Endowed Chair for Uterine Cancer Research at Cleveland Clinic’s Lerner Research Institute, and his lab previously identified CD55 as a driver of ovarian cancer chemoresistance. They also found CD55 underlies tumor recurrence and metastasis, findings replicated in additional cancers. Collectively, the previous studies indicated CD55 may provide a way to treat ovarian cancer, and his group has worked to determine how such a treatment would work.

The breakthrough came as Drs. Rashmi Bharti and Goutam Dey, post-doctoral fellows in Dr. Reizes’ lab, found that CD55 migrated into the cell nucleus from the surface, a location in which this protein has never been found before.

The lab started examining cells and tissues from patient samples by working with Chad Michener, M.D., and Roberto Vargas, M.D., oncologists specializing in women’s health at Cleveland Clinic. A subset of patient tumors showed the same thing: the CD55 protein was inside the nucleus of the cancer cells and setting off a response that makes the cancer more aggressive.

“Cancer cells can do unusual things ‒ co-opt existing pathways and create new pathways we didn’t know were possible,” Dr. Reizes said. “Once we discovered this new pathway, we wanted to see if we could find a way to block CD55 from moving into the nucleus. And then, once we prevented that move from occurring, we needed to determine whether we could halt the cancer’s progression.”

The study showed blocking CD55’s migration from the cell surface to the nucleus disrupted cancer growth and lessened the cell’s resistance to chemotherapy.

Ovarian cancer is the second most common gynecologic cancer in the U.S. and the most common cause of death. The disease’s vague symptoms often lead to late-stage diagnosis, complicating treatment. Gynecologic cancer patients commonly see the cancer recur and develop resistance to chemotherapy. Ovarian cancer cells ‒ especially cancer stem cells ‒ can survive chemotherapy drugs. Dr. Reizes’ lab investigates chemoresistance biomarkers and targeted therapies.

Ovarian cancer treatment often involves waiting for one treatment to fail before trying something new. This study’s findings may allow doctors and patients to decide to avoid chemotherapy if CD55 is already present in the cell nucleus. With the knowledge from the current findings, the lab is investigating therapeutic approaches including peptide-based, small molecule drugs and antibodies to stop CD55 from migrating to the nucleus. Moreover, the Reizes team, in collaboration with Drs. Michener and Vargas, is validating nuclear CD55 as a chemoresistance marker in gynecologic cancers as well as other solid tumors.

“These newly identified markers could allow us to track these cancers as they change in real-time,” Dr. Vargas said. “How amazing would it be to adapt our treatments as a tumor is evolving, instead of waiting for negative results months later? These approaches, thanks to Dr. Reizes’ findings, may finally allow us to remain a step ahead.”



Journal

Molecular Cancer

Subject of Research

People

Article Title

Cleveland Clinic Research Findings May Lead to Improved Treatments for Chemotherapy-Resistant Ovarian Cancer

Article Publication Date

10-Jun-2024

COI Statement

None

Share26Tweet17
Previous Post

Webb named Fellow of the American Society of Agricultural and Biological Engineers

Next Post

Researchers demonstrate new way to ‘squeeze’ infrared light

Related Posts

Cancer

Histone Drugs Target Adenoid Cystic Carcinoma Cells

August 7, 2025
blank
Cancer

Rewrite Advanced nanotheranostic approaches for targeted glioblastoma treatment: a synergistic fusion of CRISPR-Cas gene editing, AI-driven tumor profiling, and BBB-modulation as a headline for a science magazine post, using no more than 8 words

August 7, 2025
blank
Cancer

Insights on Pediatric Gastrojejunostomy Tube Replacement

August 7, 2025
blank
Cancer

Diabetes and Breast Cancer Link in Adults

August 7, 2025
blank
Cancer

Duloxetine Blocks Breast Cancer via AKT and Apoptosis

August 7, 2025
blank
Cancer

CT Patterns of Infant Head Injury from Low-Velocity Trauma

August 7, 2025
Next Post
Thin Film Membranes That Can Squeeze Infrared Light

Researchers demonstrate new way to ‘squeeze’ infrared light

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27530 shares
    Share 11009 Tweet 6881
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    942 shares
    Share 377 Tweet 236
  • Bee body mass, pathogens and local climate influence heat tolerance

    641 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    506 shares
    Share 202 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Mapping Depression, Anxiety, and Cognition in Pregnancy
  • Histone Drugs Target Adenoid Cystic Carcinoma Cells
  • Data-Driven Discovery of Super-Adhesive Hydrogels
  • Unified Protocol Trial Targets Emotional Disorders in Youth

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,859 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading